Literature DB >> 1930034

Systemic lupus erythematosus and pregnancy at the Royal Women's Hospital, Brisbane 1979-1989.

J L Nicklin1.   

Abstract

The management and obstetric outcome of 17 patients with systemic lupus erythematosus (SLE) complicating 42 pregnancies is presented. Similar to world figures there was a 14.3% incidence of therapeutic abortion, a 4.8% incidence of ectopic pregnancy, a 16.7% incidence of spontaneous abortion, a 23.8% incidence of prematurity, a 4.8% incidence of fetal death in utero (FDIU) and a 9.5% incidence of intrauterine growth retardation (IUGR). In patients with antiphospholipid antibodies the obstetric outcome was significantly worse. Pregnancies complicated by preexisting renal compromise all concluded with an adverse outcome to the conceptus. In light of the experiences at the Royal Women's Hospital and a review of the world literature, the need for a standardized approach to SLE in pregnancy and more importantly the need for a large, prospective randomized trial of low dose aspirin in these pregnancies is highlighted.

Entities:  

Mesh:

Year:  1991        PMID: 1930034     DOI: 10.1111/j.1479-828x.1991.tb01800.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  3 in total

Review 1.  Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.

Authors:  A M Lynch; J E Salmon
Journal:  Placenta       Date:  2010-04-27       Impact factor: 3.481

2.  Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia.

Authors:  Danieli Andrade; Mimi Kim; Luz P Blanco; S Ananth Karumanchi; Gloria C Koo; Patricia Redecha; Kyriakos Kirou; Angela M Alvarez; Melissa J Mulla; Mary K Crow; Vikki M Abrahams; Mariana J Kaplan; Jane E Salmon
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

3.  Cross-sectional analysis of adverse outcomes in 1,029 pregnancies of Afro-Caribbean women in Trinidad with and without systemic lupus erythematosus.

Authors:  Mariam Molokhia; Noreen Maconochie; Alan Leslie Patrick; Pat Doyle
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.